AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Kaul, R Plummer, F Clerici, M Bomsel, M Lopalco, L Broliden, K
Citation: R. Kaul et al., Mucosal IgA in exposed, uninfected subjects: evidence for a role in protection against HIV infection, AIDS, 15(3), 2001, pp. 431-432

Authors: Lopalco, L Pastori, C Cosma, A Burastero, SE Capiluppi, B Boeri, E Beretta, A Lazzarin, A Siccardi, AG
Citation: L. Lopalco et al., Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity, AIDS RES H, 16(2), 2000, pp. 109-115

Authors: Pastori, C Barassi, C Piconi, S Longhi, R Villa, ML Siccardi, AG Clerici, M Lopalco, L
Citation: C. Pastori et al., HIV neutralizing IgA in exposed seronegative subjects recognise an epitopewithin the gp41 coiled-coil pocket, J BIOL REG, 14(1), 2000, pp. 15-21

Authors: Barassi, C De Santis, C Pastori, C Marraccini, P Ciuffreda, D Capiluppi, B Bressi, C Siccardi, AG Lazzarin, A Tambussi, G Lopalco, L
Citation: C. Barassi et al., Early production of HIV-1 neutralising antibodies in patients following highly active antiretroviral treatment (HAART) during primary HIV infection, J BIOL REG, 14(1), 2000, pp. 68-74

Authors: Clerici, M Butto, S Lukwiya, M Saresella, M Declich, S Trabattoni, D Pastori, C Piconi, S Fracasso, C Fabiani, M Ferrante, P Rizzardini, G Lopalco, L
Citation: M. Clerici et al., Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5, AIDS, 14(14), 2000, pp. 2083-2092

Authors: Devito, C Hinkula, J Kaul, R Lopalco, L Bwayo, JJ Plummer, F Clerici, M Broliden, K
Citation: C. Devito et al., Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate, AIDS, 14(13), 2000, pp. 1917-1920

Authors: Devito, C Broliden, K Kaul, R Svensson, L Johansen, K Kiama, P Kimani, J Lopalco, L Piconi, S Bwayo, JJ Plummer, F Clerici, M Hinkula, J
Citation: C. Devito et al., Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells, J IMMUNOL, 165(9), 2000, pp. 5170-5176

Authors: Lopalco, L Barassi, C Pastori, C Longhi, R Burastero, SE Tambussi, G Mazzotta, F Lazzarin, A Clerici, M Siccardi, AG
Citation: L. Lopalco et al., CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro, J IMMUNOL, 164(6), 2000, pp. 3426-3433

Authors: Lopalco, L Magnani, Z Confetti, C Brianza, M Saracco, A Ferraris, G Lillo, F Vegni, C Lazzarin, A Siccardi, AG Burastero, SE
Citation: L. Lopalco et al., Anti-CD4 antibodies in exposed seronegative adults and in newborns of HIV type 1-seropositive mothers: A follow-up study, AIDS RES H, 15(12), 1999, pp. 1079-1085

Authors: Pesenti, E Pastore, C Lillo, F Siccardi, AG Vercelli, D Lopalco, L
Citation: E. Pesenti et al., Role of CD4 and CCR5 levels in the susceptibility of primary macrophages to infection by CCR5-dependent HIV type 1 isolates, AIDS RES H, 15(11), 1999, pp. 983-987

Authors: Lisziewicz, J Rosenberg, E Lieberman, J Jessen, H Lopalco, L Siliciano, R Walker, B Lori, F
Citation: J. Lisziewicz et al., Control of HIV despite the discontinuation of antiretroviral therapy, N ENG J MED, 340(21), 1999, pp. 1683-1684

Authors: Mazzoli, S Lopalco, L Salvi, A Trabattoni, D Lo Caputo, S Semplici, F Biasin, M Ble, C Cosma, A Pastori, C Meacci, F Mazzotta, F Villa, ML Siccardi, AG Clerici, M
Citation: S. Mazzoli et al., Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons, J INFEC DIS, 180(3), 1999, pp. 871-875

Authors: Morsica, G Tambussi, G Sitia, G Novati, R Lazzarin, A Lopalco, L Mukenge, S
Citation: G. Morsica et al., Replication of hepatitis C virus in B lymphocytes (CD19(+)), BLOOD, 94(3), 1999, pp. 1138-1139
Risultati: 1-13 |